Research Insights
Research Insights section focuses on the cutting-edge and breakthrough research that is happening all over the world. Laboratories across the globe are working hard to develop drugs and therapies for various diseases and research insights directly from them add tremendous value.
Genetic Risk for Neurodegenerative Conditions is Linked to Disease-specific Microglial Pathways
Genomewide association studies have identified thousands of common variants associated with an increased risk of neurodegenerative disorders However the noncoding localization of these variants has made the assignment
An Expandable Synthetic Library of Human Paired Antibody Sequences
The potential diversity in the global repertoire of human antibody sequences is currently not well understood due to the limited existing paired antibody heavylight chain sequence data that has been hindered by the low throughput and high costs of current
Mathematical Modeling Unveils the Timeline of CAR-T Cell Therapy and Macrophage-mediated Cytokine Release Syndrome
Chimeric antigen receptor CART cell therapy holds significant potential for cancer treatment although disease relapse and cytokine release syndrome CRS remain as frequent clinical challenges
Human Genetic Evidence Enriched for Side Effects of Approved Drugs
Safety failures are an important factor in low drug development success rates Human genetic evidence can select drug targets causal in disease and enrich for successful programs Here we sought to determine whether human genetic evidence can also enrich for labeled side effects SEs of approved drugs
Simulation-based Validation of a Method to Detect Changes in SARS-CoV-2 Reinfection Risk
Given the high global seroprevalence of SARSCoV understanding the risk of reinfection has become increasingly important Models developed to track trends in reinfection risk should be robust against possible biases arising from imperfect data
An Integrative Network Approach for Longitudinal Stratification in Parkinson’s Disease
Parkinsons disease PD is a neurodegenerative disorder characterized by motor symptoms resulting from the loss of dopamineproducing neurons in the brain Currently there is no cure for the disease which is in part due to the heterogeneity in patient symptoms
Unknotting RNA: A Method to Resolve Computational Artifacts
To summarize the existing evidence from doubleblind randomized controlled trials RCTs and cohort studies regarding the effects of biologic agents for the treatment of large vessel vasculitis
Identification of Potential Biomarkers for Lung Cancer Using Integrated Bioinformatics and Machine Learning Approaches
Lung cancer is one of the most common cancer and the leading cause of cancerrelated death worldwide Early detection of lung cancer can help reduce the death rate therefore the identification of potential biomarkers is crucial Thus this study aimed to identify potential biomarkers for lung cancer by integrating bioinformatics analysis and machine le...
mRNA Stability Fine-tunes Gene Expression in the Developing Cortex to Control Neurogenesis
RNA abundance is controlled by rates of synthesis and degradation Although misregulation of RNA turnover is linked to neurodevelopmental disorders how it contributes to cortical development is largely unknown Here we discover the landscape of RNA stability regulation in the cerebral cortex and demonstrate that intact RNA decay machinery is essentia...
Biologic Therapies for the Treatment of Large Vessel Vasculitis: A Systematic Review and Meta-analysis
To summarize the existing evidence from doubleblind randomized controlled trials RCTs and cohort studies regarding the effects of biologic agents for the treatment of large vessel vasculitis Large vessel vasculitis LVV is vasculitis with aorta and major branches involved including two main subtypes